ISBN:
9780833076465
,
0833076469
Language:
English
Pages:
1 Online-Ressource (1 PDF file (11 pages)))
Series Statement:
Occasional paper
Parallel Title:
Print version Mattke, Soeren Medicines as a Service : A New Commercial Model for Big Pharma in the Postblockbuster World
Keywords:
Pharmaceutical industry
;
Pharmaceutical services
;
Pharmaceutical industry
;
Pharmaceutical services
;
Drug Industry economics
;
Developing Countries
;
Chronic Disease drug therapy
;
Models, Theoretical
;
Medication Adherence
;
Pharmaceutical industry
;
Pharmaceutical services
;
MEDICAL ; Pharmacology
;
Electronic books
Abstract:
The pharmaceutical industry can reconfigure its considerable resources to develop innovative and meaningful business models that are based on services related to prescription drugs for chronic conditions. We argue that such innovation beyond the pill is consistent with the core capabilities of large pharmaceutical companies and has the potential to achieve profit levels similar to those of its traditional models. Our argument is based on the fact that, although effective medicines for most chronic conditions exist, access and adherence to medicines are far from what would be needed to achieve full treatment efficacy. Therefore, value can be created by getting and keeping more patients on their drugs, and innovative business models would allow pharmaceutical companies to capture that value
Abstract:
The pharmaceutical industry can reconfigure its considerable resources to develop innovative and meaningful business models that are based on services related to prescription drugs for chronic conditions. We argue that such innovation beyond the pill is consistent with the core capabilities of large pharmaceutical companies and has the potential to achieve profit levels similar to those of its traditional models. Our argument is based on the fact that, although effective medicines for most chronic conditions exist, access and adherence to medicines are far from what would be needed to achieve full treatment efficacy. Therefore, value can be created by getting and keeping more patients on their drugs, and innovative business models would allow pharmaceutical companies to capture that value
Note:
Includes bibliographical references
,
Title from PDF caption
URL:
Volltext
(kostenfrei)
